Figure 4.
Association of circulating RAS mutation allele fraction (MAF) with primary tumor and metastases location. (A) circulating MAF levels in patients with tumor located in the body-tail or the head of the pancreas; (B) circulating MAF levels in patients with metastatic lesions in the liver or elsewhere (* p < 0.05, ** p < 0.01).
